Why is J B Chemicals & falling/rising?

As of 30-Jul, J B Chemicals & Pharmaceuticals Ltd is currently priced at 1,787.10, reflecting a decrease of 15.35 points, or 0.85%. The stock has shown a positive performance over the past week and month, with returns of +5.81% and +6.39%, respectively, while it has underperformed its sector today by 1.19%. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally upward trend in the short term. However, the company reported flat results for March 25, with a decline in profit before tax and profit after tax compared to previous quarters, which may have contributed to the current price drop. Despite a high return on equity of 19.49% and a low debt-to-equity ratio of 0.02, the stock's valuation is considered expensive with a price-to-book value of 8.1, which could deter some investors.
In the broader market context, J B Chemicals has outperformed the Sensex over the past week and month, while it has underperformed year-to-date and over the past year, with a return of -3.08% compared to the Sensex's +4.28%. This indicates that while the stock has shown resilience in the short term, its longer-term performance remains weak relative to the overall market. The high institutional holdings at 37.4% suggest that knowledgeable investors are backing the company, but the flat quarterly results and high valuation may be causing caution among retail investors, contributing to the stock's recent decline.